Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Regan, Meredith M. and Neven, Patrick and Giobbie-Hurder, Anita and Goldhirsch, Aron and Ejlertsen, Bent and Mauriac, Louis and Forbes, John F. and Smith, Ian and Láng, István and Wardley, Andrew and Rabaglio, Manuela and Price, Karen N. and Gelber, Richard D. and Coates, Alan S. and Thürlimann, Beat and International Breast Cancer Study Group, . (2011) Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. The Lancet oncology, Vol. 12, H. 12. pp. 1101-1108.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6006981

Downloads: Statistics Overview

Abstract

Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine therapies for this patient population need extended follow-up. We present an update of efficacy outcomes in the Breast International Group (BIG) 1-98 study at 8·1 years median follow-up.

Faculties and Departments:	03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Onkologie 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Onkologie
UniBasel Contributors:	Thürlimann, Beat
Item Type:	Article, refereed
Article Subtype:	Research Article
Publisher:	Elsevier
ISSN:	1470-2045
Note:	Publication type according to Uni Basel Research Database: Journal article
Identification Number:	doi: 10.1016/S1470-2045(11)70270-4
Last Modified:	27 Mar 2014 13:13
Deposited On:	27 Mar 2014 13:13

Repository Staff Only: item control page